4th Quarter - Report
THE LIVINGSTON GROUP, LLC for INNOVATIVE VACCINE TECHNOLOGIES
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
FY2025 appropriations for the development of a synthetic vaccine
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL CAMBON | — |
| ROBERT L LIVINGSTON | — |
| J ALLEN MARTIN | — |
Budget/Appropriations BUD
FY2025 appropriations for the development of a synthetic vaccine
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL CAMBON | — |
| ROBERT L LIVINGSTON | — |
| J ALLEN MARTIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.